253 related articles for article (PubMed ID: 14552702)
41. Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.
Hüll M; Müksch B; Akundi RS; Waschbisch A; Hoozemans JJ; Veerhuis R; Fiebich BL
Neurochem Int; 2006 Jun; 48(8):663-72. PubMed ID: 16546299
[TBL] [Abstract][Full Text] [Related]
42. Aspirin and NSAID sensitivity.
Stevenson DD
Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
[TBL] [Abstract][Full Text] [Related]
43. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
[TBL] [Abstract][Full Text] [Related]
44. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs.
Ferencik M; Novak M; Rovensky J; Rybar I
Bratisl Lek Listy; 2001; 102(3):123-32. PubMed ID: 11433600
[TBL] [Abstract][Full Text] [Related]
45. [Is there a future for COX-2 inhibitors?].
Yodfat Y
Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
[TBL] [Abstract][Full Text] [Related]
46. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
McGeer PL
Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
[TBL] [Abstract][Full Text] [Related]
47. Neuroinflammation, COX-2, and ALS--a dual role?
Consilvio C; Vincent AM; Feldman EL
Exp Neurol; 2004 May; 187(1):1-10. PubMed ID: 15081582
[TBL] [Abstract][Full Text] [Related]
48. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
49. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
50. Anti-inflammatory drugs: a hope for Alzheimer's disease?
Hüll M; Lieb K; Fiebich BL
Expert Opin Investig Drugs; 2000 Apr; 9(4):671-83. PubMed ID: 11060701
[TBL] [Abstract][Full Text] [Related]
51. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
de Jong D; Jansen RW; Verbeek MM; Kremer HP
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease.
Aisen PS
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S35-40. PubMed ID: 11992749
[TBL] [Abstract][Full Text] [Related]
53. The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.
Hoozemans JJ; O'Banion MK
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):307-15. PubMed ID: 15975032
[TBL] [Abstract][Full Text] [Related]
54. Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42.
Bate C; Veerhuis R; Eikelenboom P; Williams A
Neuroreport; 2003 Nov; 14(16):2099-103. PubMed ID: 14600505
[TBL] [Abstract][Full Text] [Related]
55. [The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease].
Cakała M; Strosznajder JB
Neurol Neurochir Pol; 2010; 44(1):65-79. PubMed ID: 20358486
[TBL] [Abstract][Full Text] [Related]
56. [COX plays a pivotal role in the progressive neuronal loss in neurodegenerative diseases].
Gao JP; Sun S; Li WW; Zhao H; Cai DF
Sheng Li Ke Xue Jin Zhan; 2008 Jul; 39(3):214-20. PubMed ID: 18819488
[TBL] [Abstract][Full Text] [Related]
57. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
58. [New aspects of neuroprotective effects of nonsteroidal anti-inflammatory drugs].
Asanuma M; Miyazaki I; Tsuji T; Ogawa N
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Jun; 23(3):111-9. PubMed ID: 12884751
[TBL] [Abstract][Full Text] [Related]
59. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
Klegeris A; McGeer PL
Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
[TBL] [Abstract][Full Text] [Related]
60. [Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
Shen JN; Xu LX; Wang R
Yao Xue Xue Bao; 2013 Dec; 48(12):1743-54. PubMed ID: 24689230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
